Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Central Drugs Standard...

    Tag: central drugs standard control organization

    You Searched For "Central Drugs Standard Control Organization"
    Technical Committee recommends CDSCO to approve import, marketing of Sanofi TB drug with clinical trial waiver

    Technical Committee recommends CDSCO to approve import, marketing of Sanofi TB drug with clinical trial waiver

    Farhat Nasim28 May 2019 4:21 PM IST
    New Delhi: Apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has been recommended by the Techincal Committee to granted...
    CDSCO rejects GSK request to skip Phase III trial for Influenza Vaccine for higher age groups

    CDSCO rejects GSK request to skip Phase III trial for Influenza Vaccine for higher age groups

    Meghna A Singhania22 May 2019 5:25 PM IST
    New Delhi: One of the oldest pharmaceutical and healthcare companies in India, GlaxoSmithKline recently presented before the Subject Expert Committee...
    CDSCO denies approval for Akums Acid reflux FDC in Capsule form

    CDSCO denies approval for Akums Acid reflux FDC in Capsule form

    Meghna A Singhania8 May 2019 10:15 AM IST
    New Delhi: In order to expand its portfolio, Akum Drugs & Pharmaceuticals Ltd. presented before the Subject Experts Committee (SEC) functional...
    CDSCO expert committee suggests ban of yet another 324 FDCs

    CDSCO expert committee suggests ban of yet another 324 FDCs

    Meghna A Singhania15 April 2019 11:49 AM IST
    New Delhi: Domestic drugmakers are likely to face a blow as 324 Fixed Dose Combination (FDCs) drugs have been recommended to be banned by an expert...
    Upload application in SUGAM as per new Rules: CDSCO issues notice

    Upload application in SUGAM as per new Rules: CDSCO issues notice

    Meghna A Singhania13 April 2019 1:39 PM IST
    New Delhi: Through a recent notice, the Central Drugs Standard Control Organization (CDSCO) has informed that uploading of applications through SUGAM...
    FDC Rationality: Now 6 months accelerated stability study data to be submitted, directs DCGI

    FDC Rationality: Now 6 months accelerated stability study data to be submitted, directs DCGI

    Meghna A Singhania27 March 2019 4:48 PM IST
    New Delhi: Manufacturers of Fixed Dose Combinations drugs ( FDC drugs) which have declared rational and approved by Drugs Controller General India...
    Manufacturers of SGLT2 inhibitor Drugs to have to INCLUDE safety WARNING in package: CDSCO

    Manufacturers of SGLT2 inhibitor Drugs to have to INCLUDE safety WARNING in package: CDSCO

    Farhat Nasim26 March 2019 1:28 PM IST
    New Delhi: Paying heed to the safety updates of Sodium-Glucose Cotransporter-2 (SGLT2) including medicines such as Canagliflozin, Dapagliflozin,...
    J&J passes asbestos test, allowed to make baby powder in India

    J&J passes asbestos test, allowed to make baby powder in India

    Farhat Nasim1 March 2019 2:28 PM IST
    NEW DELHI: In a major relief to Johnson & Johnson(J&J), no asbestos was found in the baby powder manufactured in Baddi and Mulund plants. The...
    Another trouble for J&J: CDSCO seize samples of baby products for testing

    Another trouble for J&J: CDSCO seize samples of baby products for testing

    Farhat Nasim22 Dec 2018 12:14 PM IST
    The action by CDSCO has come at a time when the company is already embroiled in a controversy over its faulty hip implants. New Delhi: Following...
    CDSCO tightens safety and labelling rules for ISOTRETINOIN,prescription of dermatologist mandatory

    CDSCO tightens safety and labelling rules for ISOTRETINOIN,prescription of dermatologist mandatory

    Farhat Nasim21 Dec 2018 1:06 PM IST
    In light of concerns raised regarding Isotretinoin, the matter has been examined by CDSCO in consultation with the Subject Expert Committee...
    Asbestos scare: CDSCO draws samples of J&J baby powder from HP plant

    Asbestos scare: CDSCO draws samples of J&J baby powder from HP plant

    Medical Dialogues Bureau20 Dec 2018 5:12 PM IST
    The CDSCO, under the Union Health Ministry, said over the next four to five days, drug inspectors will search manufacturing plants and wholesalers of...
    Final regulations on e pharmacy likely by December-end, says DCGI

    Final regulations on e pharmacy likely by December-end, says DCGI

    Farhat Nasim8 Dec 2018 10:29 AM IST
    In September, the Union health ministry came out with draft rules on the sale of drugs by e pharmacies. Panaji: The union government is expected to...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok